Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1007 of 5804
-
New combo approach aims to stop pneumonia in ventilated patients
Prevention Not yet recruitingThis trial will study the impact of a combined strategy to prevent microaspiration of oropharyngeal secretions or gastric content using automated subglottic secretion drainage and/or continuous cuff pressure monitoring. These measures aim at preventing secretions of oropharyngeal…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Could skipping chemo be safer for early rectal cancer?
Disease control Recruiting nowThe goal of this clinical trial is to learn if close follow-up alone (active surveillance) works as well as radiation combined with chemotherapy (chemoradiotherapy) after removing early rectal cancer in adults. The main questions it aims to answer are: 1. Does active surveillanc…
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a headset lift depression? new trial tests home Brain-Zap therapy
Symptom relief Recruiting nowThe purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with major depression. As …
Phase: NA • Sponsor: Ionclinics & Deionic SL • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Smart wristbands may spot malaria before symptoms strike
Diagnosis Not yet recruitingIn order to control infections, the investigators must first detect them. Biosensor devices may allow early detection and intervention for infectious diseases, helping the investigators to recognize infections early, and allow for early treatment. This will lower transmission of …
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jun 27, 2026 12:27 UTC
-
AI could help ultrasound spot ovarian cancer earlier
Diagnosis OngoingThe ASTOM study is a monocentric prospective observational pilot study conducted at the Gynecologic Oncology Unit of the IRCCS Azienda Ospedaliero-Universitaria of Bologna. This study is aimed at evaluating the application of artificial intelligence to ultrasound screening for ov…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Smart radiation: new trial aims to zap lingering lymphoma cells
Disease control Not yet recruitingThis prospective feasibility study evaluates a minimal residual disease (MRD)-adapted treatment strategy in patients with diffuse large B-cell lymphoma (DLBCL) receiving frontline chemoimmunotherapy. Circulating tumor DNA (ctDNA)-based MRD testing and interim positron emission to…
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heated chemo during surgery may help fight stomach cancer spread
Disease control Recruiting nowThis trial will administer laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis from gastric cancer (GPC) who are receiving standard of care systemic chemotherapy.
Phase: PHASE2 • Sponsor: Mohammad Haroon Asif Choudry • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Pharmacists join fight against lung cancer with simple blood test
Diagnosis Recruiting nowThe U.S. Preventive Services Task Force recommends annual lung cancer screening (LCS) with low-dose CT for adults aged 50-80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years. Despite insurance coverage, only 17% of eligible Iowans were scr…
Phase: NA • Sponsor: Jill Kolesar • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough lymphoma: experimental drug GSK5926371 enters human trials
Disease control Not yet recruitingThe goal of this clinical trial is to learn if drug GSK5926371 works to treat a form of B-cell cancer (a type of blood cancer) that has returned or failed to respond to prior therapies in adults. The study will primarily assess the drugs safety and tolerability in participants. A…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill could help millions with stubborn high cholesterol
Disease control Not yet recruitingThis trial is a multicenter randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Phase: PHASE3 • Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Brain tumor drug delivered via pump shows promise in early trial
Disease control Recruiting nowThe primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of the chemotherapeutic drug Topotecan for patients with recurrent malignant glioma that harbors the Isocitrate Dehydrogenase mutation (IDH-mut). The secondary goal of the stud…
Phase: PHASE1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New nerve graft could spare patients a second surgery
Disease control Recruiting nowThis is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and …
Phase: PHASE4 • Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New oral drug INT-210 aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowA Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristic…
Phase: PHASE1, PHASE2 • Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Dissolvable magnesium stent could revolutionize heart disease treatment
Disease control Recruiting nowThe objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could earlier breathing help in ALS? new trial aims to find out
Disease control Recruiting nowAmyotrophic lateral sclerosis (ALS) is a disease that causes weakness of the muscles of the body. The disease can eventually lead to severe breathing problems, which is the most common cause of death from ALS. The treatment for breathing is non-invasive ventilation (NIV). It is a…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New ECMO technique aims to bridge lung transplant patients safely to surgery
Disease control Recruiting nowThe purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-RVF) patients to lung transplant safely.
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a common diabetes drug help fight brain tumors?
Disease control Recruiting nowSitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it is effective at treating gliomas that have returned or progressed after treatment, and 2) find out what the highest dose of sitagliptin is appropriate to give when combined wit…
Phase: PHASE1 • Sponsor: Kailin Yang, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to fight Obesity-Linked inflammation
Disease control Recruiting nowThe purpose of this study is to learn about the effects of BGE-102 on blood biomarkers including hsCRP, which is a lab value used to measure inflammation. BGE-102 decreases inflammation which may improve obesity and cardiovascular health. Participants will receive either BGE-102 …
Phase: PHASE2 • Sponsor: BioAge Labs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Bacteria in the mouth and gut may predict who responds to cancer immunotherapy
Knowledge-focused Recruiting nowThis is a prospective observational cohort study conducted at Fundación CTIC in Bogotá, Colombia. It characterizes the oral, fecal and intratumoral microbiome of Colombian adults with advanced solid tumors (gastric, colorectal, breast, cervical and head-and-neck cancer) who recei…
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a diabetes drug curb alcohol cravings and save livers?
Disease control Recruiting nowBackground: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, obesity, and other issues that can accompany AUD. MetALD can be fatal. An approved weight management drug (Tirzepatide) ma…
Phase: PHASE2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC